New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
08:27 EDTA, GENEGenetic Technologies says Agilent denied motion to dismiss patent suit
Genetic Technologies (GENE) announced that the United States District Court for the Northern District of California has last week issued an Order denying a motion brought by Agilent Technologies (A) to dismiss the patent infringement law suit brought against it by GTG. This action was initially brought by GTG against Agilent in 2011, in the District Court of Colorado, but was then moved at the request of Agilent to the District Court in the Northern District of California. GTG Acting CEO Tom Howitt repeated: “With the removal of what some potential licensees have apparently used as a reason to delay settlement discussions, we trust that good faith negotiations will now resume in earnest.”
News For GENE;A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
10:35 EDTAOptions with increasing implied volatility
Options with increasing implied volatility: ARCP RCAP GREK RSX A
December 18, 2014
11:08 EDTAOptions with increasing implied volatility
Options with increasing implied volatility: CZR RSX HLF YPF ARCP MGM A MCD
December 17, 2014
05:41 EDTGENEGenetic Technologies says adding 77 SNPs improves predictive accuracy
Subscribe for More Information
December 16, 2014
12:05 EDTGENEGenetic Technologies subsidiary says study supports use of BREVAGenplus
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use